| Authors: |
Hobbi S; IBM Consulting, Bethesda, MD, USA.; Accenture Federal Services, Arlington, VA, USA., Saunders-Hastings P; Accenture, Ottawa, Ontario, Canada., Zhou CK; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Beers J; IBM Consulting, Bethesda, MD, USA., Srikrishnan A; IBM Consulting, Bethesda, MD, USA., Hettinger A; MedStar Health Research Institute, Washington, DC, USA.; School of Medicine, Georgetown University, Washington, DC, USA., Shenoy A; MedStar Health Research Institute, Washington, DC, USA., Burrell T; IBM Consulting, Bethesda, MD, USA., Moll K; IBM Consulting, Bethesda, MD, USA., Lloyd PC; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Shoaibi A; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wong HL; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. |
